USPTO 2015–2025 USPTO PatentsView US Corporation

INTERMOLECULAR, INC.

USPTO PatentsView assignee record — 291 granted patents across 55 technology areas, active 2015–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR).

291
Total patents granted
55
CPC technology areas
16.5
Avg claims per patent
-99%
5-year filing velocity

Portfolio overview

INTERMOLECULAR, INC. has been granted 291 US utility patents between 2015 and 2021, placing INTERMOLECULAR, INC. at rank #1,434 across all assignees tracked by PlainPatent. This portfolio spans 55 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.5 claims per patent with primary concentration in H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR). As a US Corporation, INTERMOLECULAR, INC. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 54.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 288 in the 2015–2019 window — a -99% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. INTERMOLECULAR, INC.'s 16.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 55 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark INTERMOLECULAR, INC. against peers pursuing similar technology classes.

How does INTERMOLECULAR compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows INTERMOLECULAR holds 291 patents — placing it at rank #1,434 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2021

-50050100150200 201520162017201920202021 1
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
INTERMOLECULAR, INC. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 182 62.5%
2016 94 32.3%
2017 11 3.8%
2019 1 0.3%
2020 2 0.7%
2021 1 0.3%

Which technologies does INTERMOLECULAR, INC. patent most?

Top 15 of 55 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#1,434

Across all tracked assignees

Innovation Score

54.5 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does INTERMOLECULAR, INC. hold?
INTERMOLECULAR, INC. holds 291 US granted patents filed between 2015 and 2021, spanning 55 technology areas.
What is INTERMOLECULAR, INC.'s Innovation Score?
INTERMOLECULAR, INC. has an Innovation Score of 54.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does INTERMOLECULAR, INC. focus on?
INTERMOLECULAR, INC.'s top technology area is H10N (ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR) with 123 patents. The company has filed patents in 55 CPC subclasses total.
Is INTERMOLECULAR, INC.'s patent filing rate increasing or decreasing?
INTERMOLECULAR, INC.'s recent filing velocity is -99% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for INTERMOLECULAR, INC.'s patents?
INTERMOLECULAR, INC.'s patents average 16.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the INTERMOLECULAR, INC. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope